Client Corner: Jerry Williamson, CEO of Sengenics

By Joshua D. Fox

Welcome to Client Corner: Perspectives from Founders, Financiers, and Friends, a new Mintz On Air podcast series hosted by Mintz Member Joshua Fox that explores the dynamics of starting and running a business, investing in a business, and helping to support a business — through insights shared by entrepreneurs, investors, and members of the start-up community. We hope these conversations will provide valuable advice to you, the listener, as you’re working to successfully build your own business, as well as inspire others who are thinking about starting a new venture.

In this episode of Client Corner, Joshua Fox chats with Jerry Williamson, CEO of Sengenics. Jerry has more than 30 years of experience in bioscience markets for life science research, diagnostics, and analytical products. Prior to Sengenics, Jerry was the CEO and a member of the Board of Directors of NanoView Biosciences. Prior to that, Jerry was President, CEO, and a director of Kew, Inc. and held senior positions at Metamark Genetics, Flagship Ventures, Molecular Devices (Danaher), Biacore (GE), and Pyrosequencing (QIAGEN).

Subscribe To Viewpoints

Published

    • Viewpoint Topics

  • Venture Capital & Emerging Companies

    • Professionals

  • Joshua D. Fox

    • Related Practices

  • Venture Capital & Emerging Companies
  • Private Equity
  • Direct Investing (M&A)
  • Growth Equity
  • Portfolio Companies
  • Investment Funds

    • Author

    Joshua D. Fox

    Member

    Joshua D. Fox is a corporate attorney at Mintz who represents clients in milestone transactions and general corporate matters throughout the business lifecycle. He focuses on the life sciences (biotechnology, diagnostics, devices) and tech industry, including digital health, software, technology-enabled services, and consumer products.